Disease Management for Coronary Artery Patients

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-01

Study Completion Date

2020-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled trial was conducted with 58 patients hospitalized in the cardiology clinic of a state hospital. Personal Information Form, Anthropometric measurements, Framingham risk score, and compliance questionnaire (CQ) were used to collect the data.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of the Education Given to the Patients Who Will Be Applied Coronary Angiography

NCT05160935

Coronary Angiography Anxiety Vital Signs +3 more

COMPLETED NA

Training Methods for a Doctrine Of Life With Healthy Heart

NCT00738231

Heart Diseases

UNKNOWN NA

Self-Efficacy and Medication Adherence in Patients With Coronary Artery Disease: A Descriptive Study

NCT06943157

Coronary Artery Disease

RECRUITING

Turkish Adaptation of Heart Health Self-efficacy and Self-Management Scale

NCT05939297

Coronary Artery Disease

COMPLETED

Motivational Interviewing Effect on Reducing Cardiovascular Disease Risk Factors

NCT06071351

Cardiovascular Diseases Motivation Nurse's Role +1 more

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Empowerment Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Single blinded, randomised-control study

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Single blinded

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

The patients in the control group received only the standard care provided by the clinicians. After the collection of post-test data, the content of the training was also explained to these patients and the study was completed by giving them the training guide.

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention

The training program was applied by the researcher who also work as an academic nurse. The contact information of the patients was obtained and the contact information of the researcher was also given to the patients. In order to consolidate the information given, the training guide was given to the patients in the intervention group. After the training, the patients in the intervention group were contacted again in the 2nd week by using face-to-face interview and in the 4th-8th and 12th weeks by phone calls. During these interviews, the questions of the patients, if any, were answered and the problems they faced regarding the disease management were tried to be solved. In the last interview, an appointment day was determined to meet face-to-face at home, workplaces or hospital according to the preferences of the patients.

Group Type ACTIVE_COMPARATOR

Patient education

Intervention Type OTHER

The data collection process of the study was carried out in two stages using data collection tools.

First stage: Personal Information Form and Compliance Questionnaire were applied to all patients in both groups. After anthropometric measurements, Framingham Risk Score was determined. The data collection forms were filled with the patients using face-to-face interview technique. The data collection process lasted for approximately 10-15 minutes. After the data collection, the patients in the intervention group were trained. No training was given to the patients in the control group but they received a "Coronary Artery Disease Management Guide".

Second stage: 12 weeks after the first interview, the patients were interviewed again face-to-face interview technique and the forms and measurements applied initially were repeated.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patient education

The data collection process of the study was carried out in two stages using data collection tools.

First stage: Personal Information Form and Compliance Questionnaire were applied to all patients in both groups. After anthropometric measurements, Framingham Risk Score was determined. The data collection forms were filled with the patients using face-to-face interview technique. The data collection process lasted for approximately 10-15 minutes. After the data collection, the patients in the intervention group were trained. No training was given to the patients in the control group but they received a "Coronary Artery Disease Management Guide".

Second stage: 12 weeks after the first interview, the patients were interviewed again face-to-face interview technique and the forms and measurements applied initially were repeated.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged 18 and over,
* diagnosed with coronary artery disease for at least 2 months,
* no hearing and vision problem,
* no perception and expression deficiency,
* not diagnosed with any psychiatric disease,
* living in Kilis province,
* voluntary to participate in the study.

Exclusion Criteria

* aged 18 under,
* diagnosed without coronary artery disease for at least 2 months,
* hearing and vision problem,
* perception and expression deficiency,
* diagnosed with any psychiatric disease,
* no living in Kilis province,
* no voluntary to participate in the study.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No